Therapeutic advances in neurological disorders · 2025
Consensus guidelines on the diagnosis and management of myasthenia gravis by the Saudi Arabia Neuromuscular and Electrodiagnostic Medicine and neuromuscular specialists from the Gulf Cooperation Council region.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alshehri Ali Mohammed, Alanazy Mohammed H, Alabdali Majed, Abuzinadah Ahmad R, Alshareef Aysha, Abulaban Ahmad, AlRoughani Raed A, Abdulla Fatema Mohamed, Hassan Ali M A, Alhatou Mohammed Ibrahim, Almadani Abubaker, Alrukn Suhail Abdulla, Alsaadi Taoufik, Al Salti Abdullah Mohammed, Shatila Ahmed, Thakre Mona Chetan, Alyahya Mossaed, Alzahmi Fatmah, AlHajjar Lynn, Alsolaihim Alanood A, Alamro Mazen, Alotaibi Muteb Khidhran, Bushnag Areej Abdulrahman, Bamaga Ahmed K, Jumah Mohammed Al
Аннотация
The introduction of numerous therapeutic advancements in the management of myasthenia gravis (MG) may add difficulties in clinical decision-making, especially when no recommendations tailored to the local context are available. For this reason, the Saudi Arabia Neuromuscular and Electrodiagnostic Medicine (SANEM) chapter of the Saudi Neurology Society launched an initiative to discuss and agree on issues related to the management of MG in the Gulf Cooperation Council (GCC) region. An expert panel from all GCC countries (Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, and Oman) was formed to develop practical recommendations using the Delphi method to facilitate the management approach of MG and enhance patient outcomes.